These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 33228503)

  • 1. [Ivabradine for Treatment of Heart Failure with Preserved Ejection Fraction].
    Babushkina GV; Shaikhlislamova GI
    Kardiologiia; 2020 Oct; 60(10):33-37. PubMed ID: 33228503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of Sadko-CHF study)].
    Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Masenko VP; Belenkov IuN
    Ter Arkh; 2006; 78(8):14-20. PubMed ID: 17078211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ivabradine treatment in a chronic heart failure patient cohort: symptom reduction and improvement in quality of life in clinical practice.
    Zugck C; Martinka P; Stöckl G
    Adv Ther; 2014 Sep; 31(9):961-74. PubMed ID: 25160945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial.
    Komajda M; Isnard R; Cohen-Solal A; Metra M; Pieske B; Ponikowski P; Voors AA; Dominjon F; Henon-Goburdhun C; Pannaux M; Böhm M;
    Eur J Heart Fail; 2017 Nov; 19(11):1495-1503. PubMed ID: 28462519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and laboratory associations of liver fibrosis indexes in patients with decompensated Chronic Heart Failure II-IV Functional Classes].
    Stolbova SK; Dragomiretskaya NA; Beliaev IG; Podzolkov VI
    Kardiologiia; 2020 Jun; 60(5):920. PubMed ID: 32515709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of SADKO-CHF study). Part 2].
    Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Masenko VP; Belenkov IuN
    Ter Arkh; 2006; 78(9):61-71. PubMed ID: 17076227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Ivabradine on Health-Related Quality of Life of Patients with Ischaemic Chronic Heart Failure.
    Sallam M; Al-Saadi T; Alshekaili L; Al-Zakwani I
    Curr Vasc Pharmacol; 2016; 14(5):481-486. PubMed ID: 27145825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 24-hour blood pressure and heart rate on the prognosis of patients with reduced and midrange LVEF.
    Mareev VY; Kapanadze LG; Kheimets GI; Mareev YV
    Kardiologiia; 2021 Jul; 61(7):4-13. PubMed ID: 34397336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effectiveness of radiofrequency ablation and repeated cardioversion in combination with antiarrhythmic drug therapy in maintaining stable sinus rhythm in patients with atrial fibrillation and heart failure].
    Seliutskii SI; Savina NM; Chapurnykh AV
    Kardiologiia; 2020 Sep; 60(8):90-97. PubMed ID: 33155964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative Evaluation of -blockers and If-Channel Inhibitor in Patients With Chronic Heart Failure and Preserved Left Ventricular Ejection Fraction].
    Kanorsky SG; Borisenko YV
    Kardiologiia; 2016 Feb; 56(2):24-29. PubMed ID: 28294745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The efficacy and safety of the combination of β-blocker bisoprolol and if inhibitor I(f) ivabradine in patients with stable angina and chronic obstructive pulmonary disease].
    Ageev FT; Makarova GV; Patrusheva IF; Orlova IaA
    Kardiologiia; 2010; 50(10):22-6. PubMed ID: 21118175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ivabradine improves quality of life in subjects with chronic heart failure compared to treatment with β-blockers: results of a multicentric observational APULIA study.
    Riccioni G; Masciocco L; Benvenuto A; Saracino P; De Viti D; Massari F; Meliota G; Buta F; Speziale G
    Pharmacology; 2013; 92(5-6):276-80. PubMed ID: 24296869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ivabradine Improves Cardiac Function and Increases Exercise Capacity in Patients with Chronic Heart Failure.
    Pei H; Miao W; Xie WZ; Wang W; Zhao D; Su GH; Zhao Z
    Int Heart J; 2019 Jul; 60(4):899-909. PubMed ID: 31308326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The risks of re-hospitalization of patients with heart failure with prolonged follow-up in a specialized center for the treatment of heart failure and in real clinical practice.].
    Vinogradova NG; Polyakov DS; Fomin IV
    Kardiologiia; 2020 Jan; 60(3):59-69. PubMed ID: 32375617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure.
    Bonnet D; Berger F; Jokinen E; Kantor PF; Daubeney PEF
    J Am Coll Cardiol; 2017 Sep; 70(10):1262-1272. PubMed ID: 28859790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New opportunities to improve the treatment effectiveness of patients with stable angina].
    Grigoryeva NY; Vilkova OE; Samolyuk MO; Kolosova KS
    Kardiologiia; 2020 Jul; 60(6):1135. PubMed ID: 32720615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of pharmacotherapy in chronic heart failure: is heart rate adequately addressed?
    Franke J; Wolter JS; Meme L; Keppler J; Tschierschke R; Katus HA; Zugck C
    Clin Res Cardiol; 2013 Jan; 102(1):23-31. PubMed ID: 22760479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and safety of long-term application of spironolactone in patients with moderate and severe chronic heart failure receiving optimal therapy].
    Skvortsov AA; Mareev VY; Chelmakina SM; Baklanova NA; Belenkov IuN
    Kardiologiia; 2007; 47(10):12-23. PubMed ID: 18260939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Features of the clinical picture and outcomes in patients from a heart transplantation waiting list with different causes of heart failure].
    Kostomarov AN; Simonenko MA; Fedorova MA; Fedotov PA
    Kardiologiia; 2020 Aug; 60(7):15-19. PubMed ID: 33155936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Use of Selective Inhibitor of If-Channels Ivabradine in Patients with Ischemic Heart Disease, Heart Failure with High Heart Rate].
    Belenkov YN; Ilgisonis IS; Naymann YI; Privalova EA; Zhito AV
    Kardiologiia; 2019 Oct; 59(10):60-65. PubMed ID: 31615388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.